Research Triangle Park, N.C., USA, 13th August 2019 / AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired
Synpromics was proud to be featured at the launch of the inaugural joint report from the Alliance for Regenerative Medicine (ARM) and the UK BioI
Synpromics joined the BSGCT in Sheffield at the end of June to share the latest progress in gene and cell therapy.
Edinburgh, UK, 16th May 2019 / Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partners
David Venables presented to a full room of investors at the ARM Cell & Gene Therapy Investor Day in New York.